Candel Therapeutics Inc. (CADL)
NASDAQ: CADL
· Real-Time Price · USD
6.05
0.01 (0.17%)
At close: Aug 15, 2025, 3:59 PM
6.10
0.74%
After-hours: Aug 15, 2025, 07:51 PM EDT
Candel Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -39.58M | -55.18M | -52.2M | -49.99M | -37.37M | -37.94M | -31.93M | -32.18M | -26.71M | -18.79M | -12.12M | -19.59M | -32.52M | -36.12M | -48.2M | -34.59M | -20.39M |
Depreciation & Amortization | 984K | 990K | 1.06M | 1.06M | 1.04M | 1.02M | 932K | 892K | 843K | 778K | 735K | 551K | 371K | 232K | 60K | 84K | 85K |
Stock-Based Compensation | 4.58M | 5.31M | 5.01M | 4.51M | 3.4M | 3.09M | 2.79M | 2.84M | 2.55M | 2.31M | 1.23M | 2.39M | 3.02M | 2.96M | 5.16M | 3.34M | 2.57M |
Other Working Capital | 2.26M | 531K | 1.16M | -671K | 342K | -570K | -1.52M | -1.61M | -2.29M | 1.28M | 2.21M | 2.03M | 1.18M | -1.54M | -1.64M | -469K | -278K |
Other Non-Cash Items | 21.34M | 23M | 19.19M | 17.56M | 4.21M | 2.06M | -2.75M | -3.11M | -8.09M | -15.78M | -13.18M | -12.96M | -8.13M | 76K | 41K | 71K | 543K |
Deferred Income Tax | n/a | n/a | -1.39M | -1.81M | -1.95M | -1.95M | -560K | -144K | n/a | n/a | -8.64M | -394K | 11.51M | 11.51M | 24.71M | 16.46M | 4.55M |
Change in Working Capital | 2.03M | 346K | 1.2M | -702K | 288K | -525K | -2.19M | -2.58M | -2.77M | 71K | 2.2M | 2.72M | 1.1M | -876K | -2.17M | -366K | 151K |
Operating Cash Flow | -27.2M | -27.02M | -28.63M | -30.87M | -31.86M | -34.24M | -33.71M | -34.28M | -34.19M | -31.42M | -29.77M | -27.28M | -24.64M | -22.22M | -20.4M | -15.01M | -12.48M |
Capital Expenditures | -12K | -16K | -60K | -163K | -326K | -457K | -686K | -798K | -1.26M | -1.3M | -1.52M | -1.7M | -1.78M | -1.83M | -1.78M | -2.12M | -1.71M |
Cash Acquisitions | n/a | n/a | 20K | 20K | 20K | 20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.64M | 20.64M | 20.66M |
Other Investing Acitivies | n/a | n/a | 20K | 20K | 20K | 177K | 157K | 157K | 157K | n/a | n/a | n/a | n/a | n/a | -6K | -12K | 8K |
Investing Cash Flow | -12K | -16K | -40K | -143K | -306K | -280K | -529K | -641K | -1.11M | -1.3M | -1.52M | -1.7M | -1.78M | -1.83M | 18.85M | 18.51M | 18.94M |
Debt Repayment | -7.5M | -9.17M | -6.67M | -4.17M | -1.67M | n/a | n/a | n/a | n/a | 19.91M | 19.91M | 19.91M | 19.91M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -121K | -121K | -121K | -121K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -791K | 1.69M | 1.2M | 1.09M | 105K | -121K | 36K | 36K | 58K | 64K | 57K | 71.41M | 71.72M | 71.83M | 71.83M | 474K | 601K |
Financial Cash Flow | 93.67M | 94.28M | 2.25M | 569K | -1.38M | -121K | 36K | 36K | 58K | 19.97M | 19.88M | 91.23M | 91.55M | 71.74M | 71.83M | 474K | 601K |
Net Cash Flow | 66.72M | 67.51M | -26.16M | -30.44M | -33.55M | -34.65M | -34.2M | -34.89M | -35.23M | -12.74M | -11.36M | 62.31M | 65.18M | 47.75M | 70.28M | 3.98M | 7.06M |
Free Cash Flow | -27.21M | -27.04M | -28.69M | -31.03M | -32.19M | -34.7M | -34.39M | -35.08M | -35.45M | -32.72M | -31.3M | -28.98M | -26.42M | -24.05M | -22.18M | -17.13M | -14.19M |